Literature DB >> 29239659

Characteristics, Properties and Analytical Methods of Paclitaxel: A Review.

Renata Carolina Alves1, Richard Perosa Fernandes2, Josimar O Eloy1, Hérida Regina Nunes Salgado1, Marlus Chorilli1.   

Abstract

Paclitaxel is a diterpenoid pseudoalkaloid, isolated from Taxus brevifolia, and is largely used as an antitumoral drug. The formulation of paclitaxel known as Taxol® employs a mixture of Cremophor EL and dehydrated ethanol, due the low drug water solubility. However, Taxol® causes some unwanted side effects due to the presence of Cremophor EL and ethanol in the formulation. Based on this, there is a need for the development of drug delivery systems to enhance the solubility, permeability and stability of paclitaxel and to promote a controlled and targeted delivery for better therapeutic effect and reduced side effects. In addition, the drug has been qualitatively and quantitatively analyzed in different delivery systems. In this context, several approaches were reported focusing on the optimization of analytical methods and development of new ones, considering the need of a fast, simple, with enough sensibility and selectivity assay, which can be a problem in some analysis. This review presents a summary of methods used in quantification of paclitaxel in different matrices, such as plasma, urine, plant extract, cells and delivery systems.

Entities:  

Keywords:  Analytical methods; drug delivery systems; paclitaxel; physicochemical properties

Mesh:

Substances:

Year:  2018        PMID: 29239659     DOI: 10.1080/10408347.2017.1416283

Source DB:  PubMed          Journal:  Crit Rev Anal Chem        ISSN: 1040-8347            Impact factor:   6.535


  16 in total

1.  In vivo Serum Enabled Production of Ultrafine Nanotherapeutics for Cancer Treatment.

Authors:  Qingxin Mu; Guanyou Lin; Zachary R Stephen; Steve Chung; Hui Wang; Victoria K Patton; Rachel N Gebhart; Miqin Zhang
Journal:  Mater Today (Kidlington)       Date:  2020-05-04       Impact factor: 31.041

Review 2.  The Role of the APC/C and Its Coactivators Cdh1 and Cdc20 in Cancer Development and Therapy.

Authors:  Christine Greil; Monika Engelhardt; Ralph Wäsch
Journal:  Front Genet       Date:  2022-06-27       Impact factor: 4.772

3.  Co-Administration Of iRGD Enhances Tumor-Targeted Delivery And Anti-Tumor Effects Of Paclitaxel-Loaded PLGA Nanoparticles For Colorectal Cancer Treatment.

Authors:  Yi Zhong; Tao Su; Qiuxiao Shi; Yanru Feng; Ze Tao; Qiuxia Huang; Lan Li; Liqiang Hu; Shengfu Li; Hong Tan; Shan Liu; Hao Yang
Journal:  Int J Nanomedicine       Date:  2019-11-01

Review 4.  Molecular mechanisms associated with chemoresistance in esophageal cancer.

Authors:  Matheus Lohan-Codeço; Maria Luísa Barambo-Wagner; Luiz Eurico Nasciutti; Luis Felipe Ribeiro Pinto; Nathalia Meireles Da Costa; Antonio Palumbo
Journal:  Cell Mol Life Sci       Date:  2022-02-03       Impact factor: 9.261

Review 5.  Treatment implications of natural compounds targeting lipid metabolism in nonalcoholic fatty liver disease, obesity and cancer.

Authors:  Can Cheng; Songming Zhuo; Bo Zhang; Xu Zhao; Ying Liu; Chaoliang Liao; Jing Quan; Zhenzhen Li; Ann M Bode; Ya Cao; Xiangjian Luo
Journal:  Int J Biol Sci       Date:  2019-06-04       Impact factor: 6.580

6.  Spectral characteristics of urine from patients with end-stage kidney disease analyzed using Raman Chemometric Urinalysis (Rametrix).

Authors:  Ryan S Senger; Meaghan Sullivan; Austin Gouldin; Stephanie Lundgren; Kristen Merrifield; Caitlin Steen; Emily Baker; Tommy Vu; Ben Agnor; Gabrielle Martinez; Hana Coogan; William Carswell; Varun Kavuru; Lampros Karageorge; Devasmita Dev; Pang Du; Allan Sklar; James Pirkle; Susan Guelich; Giuseppe Orlando; John L Robertson
Journal:  PLoS One       Date:  2020-01-10       Impact factor: 3.240

7.  Improved Antiglioblastoma Activity and BBB Permeability by Conjugation of Paclitaxel to a Cell-Penetrative MMP-2-Cleavable Peptide.

Authors:  Dan Hua; Lida Tang; Weiting Wang; Shengan Tang; Lin Yu; Xuexia Zhou; Qian Wang; Cuiyun Sun; Cuijuan Shi; Wenjun Luo; Zhendong Jiang; Huining Li; Shizhu Yu
Journal:  Adv Sci (Weinh)       Date:  2020-12-21       Impact factor: 16.806

Review 8.  Role of Calixarene in Chemotherapy Delivery Strategies.

Authors:  Rossella Basilotta; Deborah Mannino; Alessia Filippone; Giovanna Casili; Angela Prestifilippo; Lorenzo Colarossi; Gabriele Raciti; Emanuela Esposito; Michela Campolo
Journal:  Molecules       Date:  2021-06-29       Impact factor: 4.411

Review 9.  Breast cancer: Muscarinic receptors as new targets for tumor therapy.

Authors:  Alejandro Español; Agustina Salem; Yamila Sanchez; María Elena Sales
Journal:  World J Clin Oncol       Date:  2021-06-24

Review 10.  Recent advances in the development of protein-protein interactions modulators: mechanisms and clinical trials.

Authors:  Haiying Lu; Qiaodan Zhou; Jun He; Zhongliang Jiang; Cheng Peng; Rongsheng Tong; Jianyou Shi
Journal:  Signal Transduct Target Ther       Date:  2020-09-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.